Pulmonology

Doctors of all fields, including pulmonologists, are coming together to collaborate on research regarding the ongoing threat of the coronavirus.

Telehealth tools can identify someone whose symptoms are worsening and connect them to a medical professional.

The former SCCM president speaks on the risk of facing ICU-trained personnel shortages during the coronavirus spread.

Recent studies analyze the sensitivity and specificity for RT-PCR and chest CT for diagnosing coronavirus.

As medical knowledge continues to grow, Dennis Ledford. MD, explains the importance of doctors in different fields collaborating.

Roy Schoenberg, MD, MPH, discusses the populations that can most benefit from using telehealth tools and Medicare reimbursement obstacles.

With the spread of coronavirus increasing in the US, telehealth can be leveraged, but regulations need to be modified.

The approval is the third for the Boehringer Ingelheim-produced therapy and the first from the FDA for treating patients with chronic fibrosing interstitial lung diseases with a progressive phenotype.

The label update comes after findings have repeatedly shown an associated risk of neuropsychiatric events.

Advanced cystic fibrosis liver disease manifests as portal hypertension with or without cirrhosis in about 7% of patients with cystic fibrosis.

The Ready, Set, Food! co-founder discusses how research and federal advisory shapes parental understanding of immunotherapy and food allergy prevention.

The FDA announced the first approval of ProAir HFA—1 of the most popular inhalers in the US market.

New data from a study of 30 patients found specific characteristics of gut microbiota could predict the presence of pulmonary hypertension with greater than 80% accuracy.

The new low nicotine products contain 95% less nicotine than the top 100 cigarette brands in the US, according to 22nd Century Group.

A new guidance breaks ground as the first of its kind to assist physicians in screening for, and treating, vaping-associated respiratory disease syndrome.

New follow-up data shows older patients with COPD characterized by high blood eosinophil counts may benefit from the biologic.

Inovoio Pharmaceuticals will assess INO-3107 to eventually become the first drug indicated for the rare disease.

New VDAART follow-up findings show at-risk children are not safer from asthma or recurrent wheeze when their mother takes prenatal vitamin D.

An analysis of the MESA study is shedding light on the potential association between having persistent asthma and developing atrial fibrillation.

Tiotropium reduces all-cause and asthma-related hospitalizations and emergency department visits.

The oral treatment becomes the first of its kind indicated for the reduction of food allergic reaction risks and severity in the US.

New research into the role of legislation on vaping use shows certain laws may be more effective than others.

New cohort data shows significantly worsened respiratory symptoms among patients with comorbid cough and COPD.

The FDA will rule on the type 2 inflammation-targeting biologic for another indication this May.

New data shows the market-controlling e-cigarette product nearly doubled its rate of young adult users in just 1 year.